Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Caseshaematology-oncology-and-transfusion

Paeds Cases · haematology-oncology-and-transfusion

Bleeding child: diagnostic approach: Case

Clinical case of a 4-year-old boy presenting with sudden petechiae and bruising after a viral illness, worked up for immune thrombocytopenia, covering the exclusion of leukaemia and the safety-netting pathway.

paediatric long case3 min readVerification in progress

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
On this page
Study tools

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
A 4-year-old boy is referred with sudden onset of petechiae over the lower limbs and bruising over the trunk and arms over the past 24 hours. He had a viral upper respiratory tract illness ten days ago. He is afebrile, alert, and active, with no pallor, lymphadenopathy, or hepatosplenomegaly. His platelet count is 10 times 10 to the 9 per litre, haemoglobin 120 g per litre, white cell count 7.2 times 10 to the 9 per litre, and the blood film shows isolated thrombocytopenia with large platelets and no blast cells. The prothrombin time and activated partial thromboplastin time are normal.

Case discussion

Diagnosis and immediate assessment

This boy presents the classic picture of acute immune thrombocytopenia: sudden petechiae and bruising in an afebrile, otherwise well preschool child, one to two weeks after a viral illness, with isolated severe thrombocytopenia and a normal prothrombin and activated partial thromboplastin time. The bleeding pattern is primary-hemostasis (platelet-type): immediate, mucocutaneous, and petechial. The first step is to confirm the diagnosis and exclude its dangerous mimic, acute lymphoblastic leukaemia, before any treatment that could mask it. [1]

Excluding leukaemia before treatment

The blood film is the single most important test here. The absence of blast cells, the normal haemoglobin and white cell count, the absence of additional cytopenias, and the well appearance all support immune thrombocytopenia over leukaemia. Large platelets on the film reflect young, reactive platelets, consistent with peripheral destruction rather than marrow failure. Before any corticosteroid is given, the film must be reviewed, because treating leukaemia with steroids can mask the diagnosis and delay definitive chemotherapy. The absence of hepatosplenomegaly and lymphadenopathy further supports the benign diagnosis. [3]

Pathophysiology

Immune thrombocytopenia is an antibody-mediated destruction of platelets, often triggered by a recent viral infection that generates antibodies that cross-react with platelet surface glycoproteins. The platelets are opsonised and cleared by splenic macrophages, producing isolated severe thrombocytopenia. The bone marrow is normal or shows increased megakaryocytes, which is why the film shows large, young platelets. The bleeding pattern is purely primary-hemostasis, because the coagulation factors are intact, which is why the prothrombin and activated partial thromboplastin times are normal. [1]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this case. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References3ShowHide
  1. [1]van Ommen CH, Peters M The bleeding child. Part I: primary hemostatic disorders. Eur J Pediatr, 2012.PMID 21800040
  2. [3]Neunert C, Terrell DR, Arnold DM, et al American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv, 2019.PMID 31794604
  3. [4]Neunert CE, Arnold DM, Grace RF, et al The 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopenia. Blood Adv, 2024.PMID 38608258
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAplastic anaemia and bone-marrow failure: Casehaematology-oncology-and-transfusionNextBlood-component therapy in children: Casehaematology-oncology-and-transfusion